Market News & Trends
SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its SelfDose™ Patient-Controlled Injector was named…
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors
Metrion Biosciences Ltd recently announced it has acquired a portfolio of more than 2,000 small molecule potassium channel inhibitors from Japan Tobacco Inc. (JT). The…
Immunovaccine Publishes Study Comparing MOA of Platform Technology
Immunovaccine Inc. recently announced the publication of a preclinical study using magnetic resource imaging (MRI) to follow cancer peptide uptake in tumor models, and to…
Vivos Receives FDA Confirmation of RadioGel Device Classification
Vivos Inc recently announced it has been notified by the FDA that RadioGel is classified as a device for animal therapy. After 4 months of…
First Patient Treated in Mapi Pharma’s Phase II Clinical Trial
Mapi Pharma Ltd recently announced that the first patient has been treated with GA Depot in the company’s Phase II study for primary progressive multiple…
AB Biosciences & Shire Enter Development & Commercialization Agreement
AB Biosciences, Inc. and Shire plc recently announced they have entered into an agreement granting Shire an exclusive worldwide license to develop and commercialize AB…
Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial
Fibrocell Science, Inc. recently announced that it obtained allowance from the US FDA to initiate enrollment of pediatric patients in the Phase 2 portion of…
Lupin Receives Innovator Award From BioNJ
Symbiomix, a Lupin Company, received an Innovator Award from BioNJ, New Jersey’s trade association for the biotechnology community. Leadership from the company was on hand…
Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca
Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, recently announced a new clinical collaboration with AstraZeneca to evaluate the…
Evonetix Raises $12.3 Million to Advance Gene Synthesis Platform
Evonetix recently announced it has completed a $12.3-million financing to advance the development of its technology. The financing was co-led by DCVC (Data Collective) of…
LifeArc & Milner Therapeutics Institute Announce Partnership in Artificial Intelligence & Machine Learning
LifeArc and the Milner Therapeutics Institute at the University of Cambridge, recently announced a new partnership to identify and validate new drug targets in immuno-oncology…
Hovione Strengthens Inhalation Services Portfolio
Hovione recently announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities. This investment reinforces Hovione’s Services portfolio…
Cynata Announces Encouraging Results; DSMB Recommendation Next Stage
Australian stem cell and regenerative medicine company, Cynata Therapeutics, recently announced that the independent Data Safety Monitoring Board (DSMB) has recommended that Cynata’s clinical trial…
Avacta & Oncosec to Collaborate on Innovative Gene Delivery
Avacta & Oncosec to Collaborate on Innovative Gene Delivery Avacta Group plc and OncoSec Medical Incorporated recently announced they have entered into a research collaboration…
BioCryst & Idera Announce Merger to Combine Capabilities
BioCryst Pharmaceuticals, Inc. and Idera Pharmaceuticals, Inc. recently announced they have signed a definitive merger agreement to form a new enterprise focused on the development…
Voyager Therapeutics Announces FDA Clearance of IND Application for VY-AADC
Voyager Therapeutics, Inc. recently announced the US FDA has cleared the Investigational New Drug (IND) application for VY-AADC, allowing the company to formally initiate clinical…
RedHill Biopharma Announces Final Results from Phase II Study
RedHill Biopharma Ltd. recently announced top-line final results from the Phase II clinical study with BEKINDA 12 mg (RHB-102) for the treatment of diarrhea-predominant irritable…
Biolog Announces Mitochondrial Assay Breakthrough
Biolog, Inc. recently announced the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial function…
PPD & Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development
Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), and Quotient Sciences (Quotient), a drug development services organization, recently announced a new…
Marina Biotech Announces Drug Development & Licensing Agreement With Autotelic Bio
Marina Biotech, Inc. recently announced it has entered into a binding agreement with Autotelic Bio Inc., to enter into a license of Marina’s IT-103 clinical…
